Glaxosmithkline



Ebit Zmiana Data
AbbVie USD 5.65B 407M 2025-03
Amgen USD 3.6B 434M 2025-03
AstraZeneca USD 3.51B 1.3B 2025-06
Aurora Cannabis CAD 36.86M 39.25M 2024-12
Bausch Health Companies USD 587M 41M 2025-03
Bristol-Myers Squibb USD 2.26B 1.92B 2025-06
Canopy Growth CAD -23822000 22.12M 2024-12
Corcept Therapeutics USD 3.42M 21.85M 2025-03
Drreddys Laboratories INR 18.02B 1.22B 2024-12
Eli Lilly USD 3.7B 1.93B 2025-03
GlaxoSmithKline GBP 2.53B 1.1B 2025-03
Glaxosmithkline GBP 1.83B 1.76B 2024-12
J&J USD 6.94B 443M 2025-06
Merck USD 6.36B 149M 2025-06
Novartis USD -9190000000 13.87B 2025-06
Pacira USD 12.44M 43.69M 2025-03
Perrigo USD 146.6M 47.3M 2025-03
Pfizer USD 5.93B 1.31B 2025-03
Prestige Brands USD 100.89M 8.93M 2025-03
Roche Holding CHF 11.29B 2.68B 2024-06
Sanofi EUR 2.9B 824M 2025-03
Supernus Pharmaceuticals USD 48.3M 19.4M 2024-12
Takeda JPY -129729000000 187.73B 2025-03
Teva Pharmaceutical Industries USD 946M 222M 2025-03
Zoetis USD 909M 79M 2025-03


Glaxosmithkline - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.